-+ 0.00%
-+ 0.00%
-+ 0.00%
Bristol-Myers Squibb: A registered phase 2 QUINTESSENTIAL trial of a potential first-of-its-kind drug yielded positive top-line results.
Share
Listen to the news
Bristol-Myers Squibb: A registered phase 2 QUINTESSENTIAL trial of a potential first-of-its-kind drug yielded positive top-line results.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending